You just read:

Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer

News provided by

Astellas Pharma Inc.

Mar 28, 2019, 03:01 ET